| Home > Zentren > Zentrum für Operative Medizin > Klinik und Poliklinik für Unfall-, Hand- und Wiederherstellungschirurgie > Publikationen 1999
Aoki K, Didomenico E, Sims NA, Mukhopadhyay K, Neff L, Houghton A, Amling M, Levy JB, Horne WC, Baron R
The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in mev/mev mutant mice.
Bone 25: 261-267, 1999.
Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB
Rescue of the skeletal phenotype of vitamin D receptor ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses
Endocrinology 140: 4982-4987, 1999.
Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM
Ablation of the PTHrP gene or of the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development.
J. Clin. Invest. 104: 399-407, 1999.
Aoki K, Didomenico E, Sims NA, Mukhopadhyay K, Neff L, Houghton A, Amling M, Levy JB, Horne WC, Baron R
The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in mev/mev mutant mice.
Bone 25: 261-267, 1999.
Villanova I, Townsend P, Uhlmann E, Knolle J, Peymann A, Amling M, Baron R, Horton MA, Teti A
Oligodeoxynucleotide Targeted to the alphav Gene Inhibits alphav Integrin Synthesis, Impairs Osteoclast Function and Activates Intracellular Signals to Apoptosis
J. Bone Min. Res. 14: 1867-1879, 1999
Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G
A Cbfa1 dependent genetic pathway controls bone formation beyond embryonic development.
Genes & Development 13: 1025-1036, 1999.
Karsenty G, Ducy P, Starbuck M, Priemel M, Shen J, Geoffroy V, Amling M
Cbfa1 as a regulator of osteoblast differentiation and function.
Bone 25: 107-108, 1999.
Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M , Gaillard-Kelly M, Binart N, Baron R, Kelly PA
Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice.
Endocrinology 140(1):96-105, 1999.
